BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38186021)

  • 1. PROGNOSTIC IMPLICATIONS OF PD-L1 EXPRESSION AND LOSS OF PTEN IN PATIENTS WITH RHABDOMYOSARCOMA, EWING'S SARCOMA AND OSTEOSARCOMA.
    Abd Elmoneim HM; Huwait HF; Nafady-Hego H; Mohamed FA
    Exp Oncol; 2023 Dec; 45(3):337-350. PubMed ID: 38186021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune contexture of paediatric cancers.
    Thakur MD; Franz CJ; Brennan L; Brouwer-Visser J; Tam R; Korski K; Koeppen H; Ziai J; Babitzki G; Ranchere-Vince D; Vasiljevic A; Dijoud F; Marec-Bérard P; Rochet I; Cannarile MA; Marabelle A
    Eur J Cancer; 2022 Jul; 170():179-193. PubMed ID: 35660252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical analysis and prognostic significance of PD-L1, PD-1, and CD8+ tumor-infiltrating lymphocytes in Ewing's sarcoma family of tumors (ESFT).
    Machado I; López-Guerrero JA; Scotlandi K; Picci P; Llombart-Bosch A
    Virchows Arch; 2018 May; 472(5):815-824. PubMed ID: 29445891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-301a promotes cell proliferation via PTEN targeting in Ewing's sarcoma cells.
    Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
    Int J Oncol; 2016 Apr; 48(4):1531-40. PubMed ID: 26846737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-200a induces immunosuppression by promoting PTEN-mediated PD-L1 upregulation in osteosarcoma.
    Liu Z; Wen J; Wu C; Hu C; Wang J; Bao Q; Wang H; Wang J; Zhou Q; Wei L; Shen Y; Zhang W
    Aging (Albany NY); 2020 Jan; 12(2):1213-1236. PubMed ID: 31981455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive factors of the tumor immunological microenvironment for long-term follow-up in early stage breast cancer.
    Okabe M; Toh U; Iwakuma N; Saku S; Akashi M; Kimitsuki Y; Seki N; Kawahara A; Ogo E; Itoh K; Akagi Y
    Cancer Sci; 2017 Jan; 108(1):81-90. PubMed ID: 27801993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Southwest Oncology Group and Cancer and Leukemia Group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in adults with advanced osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma.
    Antman K; Crowley J; Balcerzak SP; Kempf RA; Weiss RB; Clamon GH; Baker LH
    Cancer; 1998 Apr; 82(7):1288-95. PubMed ID: 9529020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Significance of Programmed Death Ligand 1 Expression and Tumor-Infiltrating Lymphocytes in Axial Osteosarcoma.
    Liu P; Xiao Q; Zhou B; Dai Z; Kang Y
    World Neurosurg; 2019 Sep; 129():e240-e254. PubMed ID: 31128313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of interleukin 15 (IL-15) in human rhabdomyosarcoma, osteosarcoma and Ewing's sarcoma.
    Lollini PL; Palmieri G; De Giovanni C; Landuzzi L; Nicoletti G; Rossi I; Griffoni C; Frabetti F; Scotlandi K; Benini S; Baldini N; Santoni A; Nanni P
    Int J Cancer; 1997 May; 71(5):732-6. PubMed ID: 9180138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esophageal extraskeletal neoplasm Ewing's sarcoma: Case report.
    Khalid H; Hussain N; Shamshad R
    Int J Surg Case Rep; 2022 Aug; 97():107399. PubMed ID: 35926382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of phosphatase and tensin homolog and programmed cell death ligand 1 in adenosquamous carcinoma of the lung.
    Hlaing AM; Furusato B; Udo E; Kitamura Y; Souda M; Masutani M; Fukuoka J
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2764-2769. PubMed ID: 30100056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and therapeutic relevance of HER2 expression in osteosarcoma and Ewing's sarcoma.
    Scotlandi K; Manara MC; Hattinger CM; Benini S; Perdichizzi S; Pasello M; Bacci G; Zanella L; Bertoni F; Picci P; Serra M
    Eur J Cancer; 2005 Jun; 41(9):1349-61. PubMed ID: 15913990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosarcoma, Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma.
    Bennani-Baiti IM; Machado I; Llombart-Bosch A; Kovar H
    Hum Pathol; 2012 Aug; 43(8):1300-7. PubMed ID: 22245111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PD-L1/PD-1 axis expression on tumor-infiltrating immune cells and tumor cells in pediatric rhabdomyosarcoma.
    Gabrych A; Pęksa R; Kunc M; Krawczyk M; Izycka-Swieszewska E; Biernat W; Bień E
    Pathol Res Pract; 2019 Dec; 215(12):152700. PubMed ID: 31704149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN loss increases PD-L1 protein expression and affects the correlation between PD-L1 expression and clinical parameters in colorectal cancer.
    Song M; Chen D; Lu B; Wang C; Zhang J; Huang L; Wang X; Timmons CL; Hu J; Liu B; Wu X; Wang L; Wang J; Liu H
    PLoS One; 2013; 8(6):e65821. PubMed ID: 23785454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mRNA expression of programmed cell death ligand 1 and components of the phosphatidylinositol 3-kinase/AKT/phosphatase and tensin homolog pathway in epidermal growth factor receptor mutation-positive lung adenocarcinoma.
    Han K; Zhang Y
    J Cancer Res Ther; 2019; 15(4):914-920. PubMed ID: 31436252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The roles of metastasis-related proteins in the development of giant cell tumor of bone, osteosarcoma and Ewing's sarcoma.
    Dou B; Chen T; Chu Q; Zhang G; Meng Z
    Technol Health Care; 2021; 29(S1):91-101. PubMed ID: 33682749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Key Immune Checkpoint PD-1/PD-L1 Signaling Pathway Components in the Blood Serum from Patients with Bone Tumors.
    Kushlinskii NE; Alferov AA; Timofeev YS; Gershtein ES; Bulycheva IV; Bondarev AV; Shchupak MY; Sokolov NY; Polikarpova SB; Efimova MM; Dzampaev AA; Sushentsov EA; Aliev MD; Musaev ER
    Bull Exp Biol Med; 2020 Nov; 170(1):64-68. PubMed ID: 33231796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of histopathology in Ewing's sarcoma. Long-term follow-up of distal extremity primary tumors.
    Hartman KR; Triche TJ; Kinsella TJ; Miser JS
    Cancer; 1991 Jan; 67(1):163-71. PubMed ID: 1985713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia and hypoglycaemia in Ewing's sarcoma and osteosarcoma: regulation and phenotypic effects of Hypoxia-Inducible Factor.
    Knowles HJ; Schaefer KL; Dirksen U; Athanasou NA
    BMC Cancer; 2010 Jul; 10():372. PubMed ID: 20637078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.